retinal tracer targeting TDP-43 (Amydis)

N/A

Report date: 2025/03/20 14:43:56
NME

Base Information

Drug Nameretinal tracer targeting TDP-43 (Amydis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTAR DNA binding protein 43 modulators
TargetsTAR DNA binding protein 43
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmydis Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmydis Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A